Analyst Ratings for Guardant Health (GH)
GH Rating Summary
GH Price Target Summary
- Highest: $185.00 (RBC Capital)
- Lowest: $60.00 (Scotiabank)
- Average: $123.64
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$123.64 (-6.2%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Avg. $ Target:
$123.64 (-6.2%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | RBC Capital | Dan Leonard | New Coverage | Outperform (N/A) |
185.00 (N/A) |
130.70 (131.78) |
0.83% | Details |
| 6/5/2026 | Goldman Sachs | Evie Koslosky | New Coverage | Buy (N/A) |
165.00 (N/A) |
127.03 (131.78) |
3.74% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
